AI assistant
Sending…
ReposiTrak, Inc. — Director's Dealing 2012
Jan 13, 2012
33340_dirs_2012-01-13_dc0c2047-9b8b-4dbd-8cf5-208f5c3e21e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PARK CITY GROUP INC (PCYG)
CIK: 0000050471
Period of Report: 2012-01-09
Reporting Person: FIELDS RANDALL K (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-09 | Common Stock | J | 1326 | $2.59 | Acquired | 3939492 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-01-10 | Series A Convertible Preferred Stock | $10.00 | J | 83 | Acquired | Common Stock (277) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 651152 | Indirect |
| Common Stock | 30667 | Indirect |
| Common Stock | 90467 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Convertible Preferred Stock | $10.00 | Common Stock (874065) | 349626 | Indirect | |
| Series B Convertible Preferred Stock | $10.00 | Common Stock (25000) | 10000 | Indirect |
Footnotes
F1: Shares were issued in lieu of cash compensation at a 15% discount to fair market value, pursuant to the Company's Employee Stock Purchase Plan.
F2: Shares were issued in lieu of cash dividends payable on Series A Convertible Preferred Stock.
F3: Series A Convertible Preferred Stock remains convertible so long as the shares remain issued and outstanding
F4: Series B Convertible Preferred Stock remains convertible so long as the shares remain issued and outstanding
More from ReposiTrak, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 26